Skip to main content

NewcelX Ltd.

NCEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001783036

No open-market purchases or sales by NewcelX Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $42.6K in total; no superinvestor holds it.

Holders of 5% or more of NCEL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of NewcelX Ltd., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NCEL
HolderLatest formStakeChangeFirst filedLatest filingFiling
League Jinn Sarl13D25.30%1.32M shares+3.70 ppfrom 21.60%Nov 13, 20252 filingsMay 4, 2026SEC
Revel Michel13D20.20%940.8K sharesNewNov 14, 20251 filingNov 14, 2025SEC
Hafner Ronald13D13.20%557.1K shares–Nov 21, 20242 filingsJun 24, 2025SEC
Clover Wolf Capital - Limited Partnership13G7.50%343.1K sharesNewNov 7, 20251 filingNov 7, 2025SEC
Twito Ronen13D6.00%272.4K sharesNewNov 13, 20251 filingNov 13, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

29 Schedule 13D and 13G filings on NewcelX Ltd., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NCEL
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 4, 20264:26 PM ETLeague Jinn Sarland 1 other13D25.30%1.32M shares+3.70 ppfrom 21.60%Apr 27, 2026SEC
Nov 14, 20253:30 PM ETRevel Michel13D20.20%940.8K sharesNewOct 30, 2025SEC
Nov 13, 20252:12 PM ETTwito Ronen13D6.00%272.4K sharesNewOct 30, 2025SEC
Nov 13, 20258:59 AM ETLeague Jinn Sarland 1 other13G21.60%989.0K sharesNewOct 30, 2025SEC
Nov 7, 20259:41 PM ETClover Wolf Capital - Limited Partnershipand 1 other13G7.50%343.1K sharesNewOct 30, 2025SEC
Nov 4, 20256:57 PM ETBiotechnology Value Fund L Pand 9 others13G/A0.60%28.7K shares–Below 5%Oct 31, 2025SEC
Jun 24, 20254:57 PM ETHafner Ronald13D13.20%557.1K shares–May 22, 2025SEC
Feb 14, 20255:08 PM ETLind Global Fund II LPand 2 others13G/A4.90%59.8K shares–Below 5%Dec 31, 2024SEC
Nov 21, 2024Hafner Ronald13G/AOld format–––SEC
Nov 14, 2024Armistice Capital, LLC13GOld format–New–SEC
Nov 14, 2024Lind Global Fund II LP13G/AOld format–––SEC
Nov 4, 2024Grisard Felix13G/AOld format–––SEC
Nov 4, 2024YA II PN, Ltd.13G/AOld format–––SEC
Oct 15, 2024Alpha Capital Anstalt13GOld format–New–SEC
Mar 27, 2024Lind Global Fund II LP13GOld format–New–SEC
Feb 12, 2024YA II PN, Ltd.13G/AOld format–––SEC
Feb 24, 2023Grisard Felix13GOld format–New–SEC
Feb 14, 2023Magnetic Rock Investment AG13G/AOld format–––SEC
Feb 14, 2023Konofal Eric13G/AOld format–––SEC
Feb 13, 2023Zwyer Alexander13G/AOld format–––SEC
Jan 3, 2023YA II PN, Ltd.13G/AOld format–––SEC
Dec 16, 2022Biotechnology Value Fund L P13GOld format–New–SEC
Feb 24, 2022Konofal Eric13GOld format–New–SEC
Feb 18, 2022Magnetic Rock Investment AG13GOld format–New–SEC
Feb 14, 2022Zwyer Alexander13GOld format–New–SEC
Jan 11, 2022YA II PN, Ltd.13G/AOld format–––SEC
Oct 8, 2021YA II PN, Ltd.13GOld format–New–SEC
Mar 17, 2021Hirschman Orin13G/AOld format–––SEC
Feb 4, 2021Hirschman Orin13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell NewcelX Ltd. shares.

No Form 144 notices for NewcelX Ltd. are on file.